Show simple item record

dc.contributor.authorAl Ayoub, Yuosef*
dc.contributor.authorGopalan, Rajendran C.*
dc.contributor.authorNajafzadeh, Mojgan*
dc.contributor.authorMohammad, Mohammad A.*
dc.contributor.authorAnderson, Diana*
dc.contributor.authorParadkar, Anant R*
dc.contributor.authorAssi, Khaled H.*
dc.date.accessioned2019-01-31T09:54:30Z
dc.date.available2019-01-31T09:54:30Z
dc.date.issued25/02/2019
dc.identifier.citationAl Ayoub Y, Gopalan RC, Najafzadeh M et al (2019) Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of nanoparticles. International Journal of Pharmaceutics. 557: 254-263.
dc.identifier.urihttp://hdl.handle.net/10454/16775
dc.descriptionYes
dc.description.abstractExtensive research has demonstrated the potential effectiveness of curcumin against various diseases, including asthma and cancers. However, few studies have used liquid-based vehicles in the preparation of curcumin formulations. Therefore, the current study proposed the use of nanoemulsion and microsuspension formulations to prepare nebulised curcuminoid for lung delivery. Furthermore, this work expressed a new approach to understanding the aerosol performance of nanoparticles compared to microsuspension formulations. The genotoxicity of the formulations was also assessed. Curcuminoid nanoemulsion formulations were prepared in three concentrations (100, 250 and 500 µg/ml) using limonene and oleic acid as oil phases, while microsuspension solutions were prepared by suspending curcuminoid particles in isotonic solution (saline solution) of 0.02% Tween 80. The average fine particle fraction (FPF) and mass median aerodynamic diameter (MMAD) of the nebulised microsuspension formulations ranged from 26% and 7.1 µm to 40% and 5.7 µm, for 1000 µg/ml and 100 µg/ml respectively. In a comparison of the low and high drug concentrations of the nebulised nanoemulsion, the average FPF and MMAD of the nebulised nanoemulsion formulations prepared with limonene oil ranged from 50% and 4.6 µm to 45% and 5.6 µm, respectively; whereas the FPF and MMAD of the nebulised nanoemulsion prepared with oleic acid oil ranged from 46% and 4.9 µm to 44% and 5.6 µm, respectively. The aerosol performance of the microsuspension formulations were concentration dependent, while the nanoemulsion formulations did not appear to be dependent on the curcuminoids concentration. The performance and genotoxicity results of the formulations suggest the suitability of these preparations for further inhalation studies in animals.
dc.language.isoen
dc.rightsCrown Copyright © 2018 Published by Elsevier B.V. All rights reserved. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
dc.subjectNanoemulsion
dc.subjectMicrosuspension
dc.subjectCurcuminoids
dc.subjectLung delivery
dc.subjectNebuliser formulation
dc.subjectGenotoxicity
dc.titleDevelopment and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of nanoparticles
dc.status.refereedYes
dc.date.Accepted12/12/2018
dc.date.application28/12/2018
dc.typeArticle
dc.type.versionAccepted manuscript
dc.identifier.doihttps://doi.org/10.1016/j.ijpharm.2018.12.042
dc.rights.licenseCC-BY-NC-ND
refterms.dateFOA2019-01-31T09:54:30Z
dc.openaccess.statusopenAccess


Item file(s)

Thumbnail
Name:
Assi_et_al_Int_Jnl_Pharmaceuti ...
Size:
1.061Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record